Blog

Jul 13, 2020

Gilead Sciences Is Set to Break Out: How to Play It

Posted by in category: biotech/medical

Gilead Sciences (GILD) could be ready for an upside breakout on the charts. Let’s take a close look at the stock of the company behind the potential Covid-19 treatment remdesivir.


The stock is trading above the 50-day and the 200-day moving averages.

Comments are closed.